Clinical Trials Browser

Phase 1/2 × Withdrawn × Thoracic Neoplasms × Clear all

NCT04841538 2022-04-29

A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Malignant Thoracic Tumors

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms, Small Cell Lung Carcinoma